Stand Up to Cancer | GenomeWeb

Stand Up to Cancer

NEW YORK (GenomeWeb News) –The fundraising organization Stand Up To Cancer (SU2C) has provided a grant of €6 million ($8.1 million) to investigators at the Dutch Cancer Society and the American Association for Cancer Research to fund an effort to grow and study living tumors from patient samples

NEW YORK (GenomeWeb News) – A multi-organization initiative has been created with the goal of discovering new therapies for childhood cancers using genomics as well as immunotherapeutic technologies.

NEW YORK (GenomeWeb News) – The Prostate Cancer Foundation plans to use a $7 million donation from New York billionaire Stewart Rahr to fund a multi-partner research project that will use genomic medicine and other approaches to discover new prostate cancer treatments.

NEW YORK (GenomeWeb News) – A second Dream Team project has been created for translational research into prostate cancer with $10 million in funding over three years.

NEW YORK (GenomeWeb News) – A group of Dutch-led research partners will use a €1.2 million ($1.5 million) grant awarded under a collaboration with Stand Up 2 Cancer (SU2C) to fund a genomics-based project seeking to use tumor profiles to predict patient response to cancer treatments.

The multi-partner non-profit cancer research initiative has funded new high-risk, high-reward grants using exome sequencing, genomic analysis, and tumor-specific drug response studies.

These high-risk awards for young scientists will support epigenomics, molecular profiling, and other studies that could be "game-changers."

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.